NCT07503821
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
- Locations
-
- Hospices Civils de Lyon Lyon, France
- CHU de Nantes Nantes, France
- Hôpital Cochin APHP Paris, France
Clinical trial condition
Synovitis, Pigmented Villonodular
Explore clinical trials studying Synovitis, Pigmented Villonodular. Study availability and eligibility vary by location and protocol.
18 public trials
1 recruiting study
Synovitis, Pigmented Villonodular trial results
Not yet recruiting
Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor
NCT07707882
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
- Locations
-
- Department of Orthopedics, The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China
Active, not recruiting
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469
- Conditions
- Advanced Malignant Neoplasm, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +13 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado - Denver Denver, Colorado, United States
- Mayo Clinic Jacksonville, Florida, United States
- University of Miami Miami, Florida, United States
Active, not recruiting
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)
NCT05804045
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
- Locations
-
- Precision NextGen Oncology Beverly Hills, California, United States
- Duke University Medical Center Durham, California, United States
- Henry Ford Health System Detroit, Michigan, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
Active, not recruiting
Study of Vimseltinib for Tenosynovial Giant Cell Tumor
NCT05059262
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +13 more
- Locations
-
- City of Hope Duarte, California, United States
- UC Davis Comprehensive Cancer Center Sacramento, California, United States
- University of Colorado Aurora, Colorado, United States
- University of Kansas Kansas City, Kansas, United States
Active, not recruiting
Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)
NCT05417789
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
- Locations
-
- NextGen Oncology Beverly Hills, California, United States
- Sarcoma Oncology Research Center, LLC Los Angeles, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of Kansas Cancer Center (Overland Park) - USOR Overland Park, Kansas, United States
NCT04703322
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +10 more
- Locations
-
- Nagoya University Hospital Aichi, Japan
- Kyushu University Hospital Fukuoka, Japan
- Kanazawa University Hospital Ishikawa, Japan
- National Hospital Organization Osaka National Hospital Osaka, Japan
NCT01207492
- Conditions
- Diffuse-type Giant Cell Tumor, Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, +12 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
- Stanford University Medical Center Stanford, California, United States
- H. Lee Moffitt Cancer Center Tampa, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT05349643
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +12 more
- Locations
-
- AmMax Bio, Clinical Site Sacramento, California, United States
- AmMax Bio, Clinical Site Miami, Florida, United States
- AmMax Bio, Clinical Site Houston, Texas, United States
- AmMax Bio, Clinical Site Camperdown, Australia
NCT04731675
- Conditions
- Giant Cell Tumor of Tendon Sheath, Giant Cell Tumors, Joint Diseases, +11 more
- Locations
-
- AmMax Bio Clinical Site Columbus, Ohio, United States
- AmMax Bio Clinical Site Leiden, Netherlands
- AmMax Bio Clinical Site Warsaw, Poland
- AmMax Bio Clinical Site Dnipro, Ukraine